患有的成年人的并发症 - 美国,2021-2022年
Ying Zhou1,2, Rosemarie Kobau1, Daniel M Pastula1,3
1Epidemiology and Surveillance Branch, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Preventing chronic disease
|December 19, 2024
概括
患有活动性的成年人经历的非精神病性健康状况和慢性疾病显著更多. 这强调了对患者进行综合护理和查的需要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 神经学 神经学
背景情况:
- 经常与精神疾病有关,但非精神病并发症的理解较少.
- 了解中全方位的健康状况对于全面的患者护理至关重要.
研究的目的:
- 调查美国成年人患有活跃的非精神病并发症的患病率.
- 确定活跃和患有多种慢性疾病的可能性之间的关联.
主要方法:
- 分析2021年和2022年国家健康访谈调查样本成人数据.
- 在有和没有活动性的成年人之间比较并发症患病率.
主要成果:
- 大约1.2%的美国成年人 (300万) 患有活跃.
- 患有活动性的成年人显示,几乎所有21种检查的疾病的患病率都更高.
- 患有活动性的人更有可能患有四种或更多同时出现的慢性疾病.
结论:
- 活动性与广泛的非精神病医疗健康问题有关.
- 医疗保健提供者应在患者中实施针对性查和并发症的管理策略.
- 改善对护理和自我管理计划的准入对于这群人来说至关重要.
相关概念视频
Seizures: Classification
300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Prevalence and Incidence
351
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
351
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antiepileptic Drugs: Glutamate Antagonists
280
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
280
Antiepileptic Drugs: GABAergic Pathway Potentiators
325
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
325


